approval
saveNURTEC ODT (RIMEGEPANT SULFATE) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMar 16, 2026 · 203d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMar 21, 2025 · 563d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalDec 12, 2024 · 662d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalApr 11, 2022 · 1638d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMar 31, 2022 · 1649d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalDec 8, 2021 · 1762d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMay 27, 2021 · 1957d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalAug 18, 2020 · 2239d ago
same company · ±60 days · 6
- recallPfizer Inc. recall (Cls II)Aug 6, 2025
- recallPfizer Inc. recall (Cls II)Aug 6, 2025
- device pmaFerrosan Meidcal Devices A/S — SURGIFLO® Hemostatic Matrix; SURGIFLO® Hemostatic Matrix Kit with Thrombin (PMA supplement)Jul 18, 2025
- recallPfizer recall (Cls II)Aug 20, 2025
- approvalelranatamab: ELREXFIO (ELRANATAMAB) — FDA approvalJul 10, 2025
- device pmaFerrosan Meidcal Devices A/S — SURGIFLO Hemostatic Matrix Kit with Thrombin (PMA supplement)Jul 9, 2025
comments(0)
5-min edit window · permanent after that